Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results · Q1 FY27

ANG Lifesciences India Q1 FY27 Results: Net Loss of ₹4.2 Cr, Loss Widens

ANG Lifesciences India Ltd reported revenue from operations of ₹15.3 Cr (-37.8% YoY) and a net loss of ₹4.2 Cr for Q1 FY27.

Q1 FY27 at a glance · ₹ crore
MetricQ1 FY27Q4 FY26Q1 FY26
Revenue from operations15.323.524.6
Other income0.10.20.1
Total income15.423.724.7
Profit before exceptional items & tax-5.6-1.1-2.7
Profit before tax-5.6-1.1-2.7
Net profit-4.2-1.4-2.0
Operating margin-36.4%-4.6%-10.9%

A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.

Growth
Revenue, year on year-37.80%
Operating profit, year on year-103.60%
Operating profit, quarter on quarter-338.50%
Source

BSE results filing, NSE: ANG. Figures extracted from the filing.

Read the filing ↗

ANG Lifesciences India Ltd: key numbers

Share price
₹40.27
Market cap
₹52.59 Cr
Revenue (annual)
₹92.89 Cr
Net profit (annual)
₹-11.08 Cr
P/E (TTM)
-4.0×Sector 50.4×
Promoter holding
70.60%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from ANG Lifesciences India Ltd

All →
10:57 IST BSE
Other Announcement

ANG Lifesciences India Other Announcement

ANG Lifesciences India Ltd has filed its quarterly shareholding pattern as required under SEBI Regulation 31(1)(b).

22:56 IST BSE
Annual Report

ANG Lifesciences India Annual Report

ANG Lifesciences India Limited has submitted its Annual Report for the financial year 2025-26, including the notice convening its 20th Annual General Meeting.

20:33 IST BSE
Annual General Meeting

ANG Lifesciences India Annual General Meeting

ANG Lifesciences India Limited has scheduled its 20th Annual General Meeting for September 30, 2026, to be conducted via Video Conference.

20:26 IST BSE
Board Meeting Outcome

ANG Lifesciences India Board Meeting Outcome

ANG Lifesciences announced the outcome of its board meeting, approving the Board's report, appointing a cost auditor, and scheduling the 20th AGM for September 30, 2026.